Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto 602-8566 Japan.
Radiat Oncol. 2011 Jan 27;6:10. doi: 10.1186/1748-717X-6-10.
To assess inter-observer variability in delineating target volume and organs at risk in benign tumor adjacent to optic tract as a quality assurance exercise.
We quantitatively analyzed 21 plans made by 11 clinicians in seven CyberKnife centers. The clinicians were provided with a raw data set (pituitary adenoma and meningioma) including clinical information, and were asked to delineate the lesions and create a treatment plan. Their contouring and plans (10 adenoma and 11 meningioma plans), were then compared. In addition, we estimated the influence of differences in contouring by superimposing the respective contours onto a default plan.
The median planning target volume (PTV) and the ratio of the largest to the smallest contoured volume were 9.22 cm3 (range, 7.17-14.3 cm3) and 1.99 for pituitary adenoma, and 6.86 cm3 (range 6.05-14.6 cm3) and 2.41 for meningioma. PTV volume was 10.1±1.74 cm3 for group 1 with a margin of 1-2 mm around the CTV (n=3) and 9.28±1.8 cm3 (p=0.51) for group 2 with no margin (n=7) in pituitary adenoma. In meningioma, group 1 showed larger PTV volume (10.1±3.26 cm3) than group 2 (6.91±0.7 cm3, p=0.03). All submitted plan keep the irradiated dose to optic tract within the range of 50 Gy (equivalent total doses in 2 Gy fractionation). However, contours superimposed onto the dose distribution of the default plan indicated that an excessive dose 23.64 Gy (up to 268% of the default plan) in pituitary adenoma and 24.84 Gy (131% of the default plan) in meningioma to the optic nerve in the contours from different contouring.
Quality assurance revealed inter-observer variability in contour delineation and their influences on planning for pituitary adenoma and meningioma near optic tract.
为了评估良性肿瘤毗邻视束的靶区和危及器官勾画的观察者间变异性,作为质量保证的一项措施。
我们对 7 个 CyberKnife 中心的 11 名临床医生提供的 21 个计划进行了定量分析。这些临床医生提供了一个原始数据集(垂体腺瘤和脑膜瘤),包括临床信息,并被要求勾画病变并制定治疗计划。然后比较他们的勾画和计划(10 个垂体腺瘤和 11 个脑膜瘤计划)。此外,我们通过将各自的轮廓叠加到默认计划上来估计勾画差异的影响。
垂体腺瘤的中位计划靶区(PTV)和最大与最小勾画体积比分别为 9.22cm3(范围 7.17-14.3cm3)和 1.99,脑膜瘤的 PTV 分别为 6.86cm3(范围 6.05-14.6cm3)和 2.41。垂体腺瘤的组 1(CTV 周围有 1-2mm 的边界)PTV 体积为 10.1±1.74cm3(n=3),而组 2(无边界)PTV 体积为 9.28±1.8cm3(p=0.51)(n=7)。脑膜瘤中,组 1 的 PTV 体积(10.1±3.26cm3)大于组 2(6.91±0.7cm3,p=0.03)。所有提交的计划都将视神经照射剂量保持在 50Gy(2Gy 分割等效总剂量)范围内。然而,叠加到默认计划剂量分布上的轮廓表明,垂体腺瘤的视神经有 23.64Gy(高达默认计划的 268%)和脑膜瘤的视神经有 24.84Gy(默认计划的 131%)的过量剂量。
质量保证显示了垂体腺瘤和脑膜瘤毗邻视束的轮廓勾画的观察者间变异性及其对计划的影响。